---
title: How I treat secondary CNS involvement by aggressive lymphomas
date: '2023-09-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37702537/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20230914180826&v=2.17.9.post6+86293ac
source: Blood
description: Secondary central nervous system lymphoma (SCNSL) is a rare but clinically
  challenging scenario with historically disappointing outcomes. SCNSL refers to lymphoma
  that has spread into the CNS concurrently with systemic disease, or CNS relapse
  during or after frontline immunochemotherapy, presenting with or without systemic
  lymphoma. Diffuse large B-cell lymphoma (DLBCL) denotes the most common entity but
  an increased incidence is observed in other histologies such as Burkitt lymphoma
  and ...
disable_comments: true
---
Secondary central nervous system lymphoma (SCNSL) is a rare but clinically challenging scenario with historically disappointing outcomes. SCNSL refers to lymphoma that has spread into the CNS concurrently with systemic disease, or CNS relapse during or after frontline immunochemotherapy, presenting with or without systemic lymphoma. Diffuse large B-cell lymphoma (DLBCL) denotes the most common entity but an increased incidence is observed in other histologies such as Burkitt lymphoma and ...